Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants. Local targets link to admitted publications; unresolved targets remain external evidence.
Incidental Germline Variants in 1000 Advanced Cancers on a Prospective Somatic Genomic Profiling Protocol
10.1093/annonc/mdw018 · 2016 · External reference
Pathogenic Germline Variants in 10,389 Adult Cancers
10.1016/j.cell.2018.03.039 · 2018 · External reference
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
10.1001/jama.2017.7112 · 2017 · External reference
Hereditary Breast and Ovarian Cancer: New Genes in Confined Pathways
10.1038/nrc.2016.72 · 2016 · External reference
ATM Mutations That Cause Ataxia-Telangiectasia Are Breast Cancer Susceptibility Alleles
10.1038/ng1837 · 2006 · External reference
CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls
10.1200/jco.2007.12.5922 · 2008 · External reference
A Recurrent Mutation in PALB2 in Finnish Cancer Families
10.1038/nature05609 · 2007 · External reference
Truncating Mutations in the Fanconi Anemia J Gene BRIP1 Are Low-Penetrance Breast Cancer Susceptibility Alleles
10.1038/ng1902 · 2006 · External reference
Germline Mutations in Breast and Ovarian Cancer Pedigrees Establish RAD51C as a Human Cancer Susceptibility Gene
10.1038/ng.569 · 2010 · External reference
Breast-Cancer Risk in Families with Mutations in PALB2
10.1056/nejmoa1400382 · 2014 · External reference
Risk of Pancreatic Ductal Adenocarcinoma Associated with Carriage of BRCA1 and/or BRCA2 Mutation: A Systematic Review and Meta-Analysis
10.1002/jso.26994 · 2022 · External reference
The Association of BRCA1 and BRCA2 Mutations with Prostate Cancer Risk, Frequency, and Mortality: A Meta-Analysis
10.1002/pros.23795 · 2019 · External reference
Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants
10.1200/jco.21.02112 · 2022 · External reference
The Context-Specific Role of Germline Pathogenicity in Tumorigenesis
10.1038/s41588-021-00949-1 · 2021 · External reference
Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality
10.1158/1078-0432.ccr-24-2058 · 2025 · External reference
Germline Pathogenic Variants Detected by GenMineTOP: Insight from a Nationwide Tumor/Normal Paired Comprehensive Genomic Profiling Test, in Japan
10.1038/s10038-025-01389-z · 2026 · External reference
Feasibility and Utility of a Panel Testing for 114 Cancer-Associated Genes in a Clinical Setting: A Hospital-Based Study
10.1111/cas.13969 · 2019 · External reference
A Practice Guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral Indications for Cancer Predisposition Assessment
10.1038/gim.2014.147 · 2015 · External reference
Genetic Predisposition to Cancer—Insights from Population Genetics
10.1038/nrg1450 · 2004 · External reference
Risk of Pancreatic Cancer among Individuals with Pathogenic Variants in the ATM Gene
10.1001/jamaoncol.2021.3701 · 2021 · External reference
Whole Genomes Redefine the Mutational Landscape of Pancreatic Cancer
10.1038/nature14169 · 2015 · External reference
Genomic Analyses Identify Molecular Subtypes of Pancreatic Cancer
10.1038/nature16965 · 2016 · External reference
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
10.1016/j.ccell.2017.07.007 · 2017 · External reference
ATM-Deficiency Increases Genomic Instability and Metastatic Potential in a Mouse Model of Pancreatic Cancer
10.1038/s41598-017-11661-8 · 2017 · External reference
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
10.1001/jama.2017.7112 · ExternalCitation · doi-reference
Risk of Pancreatic Cancer among Individuals with Pathogenic Variants in the ATM Gene
10.1001/jamaoncol.2021.3701 · ExternalCitation · doi-reference
Risk of Pancreatic Ductal Adenocarcinoma Associated with Carriage of BRCA1 and/or BRCA2 Mutation: A Systematic Review and Meta-Analysis
10.1002/jso.26994 · ExternalCitation · doi-reference
The Association of BRCA1 and BRCA2 Mutations with Prostate Cancer Risk, Frequency, and Mortality: A Meta-Analysis
10.1002/pros.23795 · ExternalCitation · doi-reference
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
10.1016/j.ccell.2017.07.007 · ExternalCitation · doi-reference
Pathogenic Germline Variants in 10,389 Adult Cancers
10.1016/j.cell.2018.03.039 · ExternalCitation · doi-reference
A Practice Guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral Indications for Cancer Predisposition Assessment
10.1038/gim.2014.147 · ExternalCitation · doi-reference
A Recurrent Mutation in PALB2 in Finnish Cancer Families
10.1038/nature05609 · ExternalCitation · doi-reference
Whole Genomes Redefine the Mutational Landscape of Pancreatic Cancer
10.1038/nature14169 · ExternalCitation · doi-reference
Genomic Analyses Identify Molecular Subtypes of Pancreatic Cancer
10.1038/nature16965 · ExternalCitation · doi-reference
Germline Mutations in Breast and Ovarian Cancer Pedigrees Establish RAD51C as a Human Cancer Susceptibility Gene
10.1038/ng.569 · ExternalCitation · doi-reference
ATM Mutations That Cause Ataxia-Telangiectasia Are Breast Cancer Susceptibility Alleles
10.1038/ng1837 · ExternalCitation · doi-reference
Truncating Mutations in the Fanconi Anemia J Gene BRIP1 Are Low-Penetrance Breast Cancer Susceptibility Alleles
10.1038/ng1902 · ExternalCitation · doi-reference
Hereditary Breast and Ovarian Cancer: New Genes in Confined Pathways
10.1038/nrc.2016.72 · ExternalCitation · doi-reference
Genetic Predisposition to Cancer—Insights from Population Genetics
10.1038/nrg1450 · ExternalCitation · doi-reference
Germline Pathogenic Variants Detected by GenMineTOP: Insight from a Nationwide Tumor/Normal Paired Comprehensive Genomic Profiling Test, in Japan
10.1038/s10038-025-01389-z · ExternalCitation · doi-reference
The Context-Specific Role of Germline Pathogenicity in Tumorigenesis
10.1038/s41588-021-00949-1 · ExternalCitation · doi-reference
ATM-Deficiency Increases Genomic Instability and Metastatic Potential in a Mouse Model of Pancreatic Cancer
10.1038/s41598-017-11661-8 · ExternalCitation · doi-reference
Breast-Cancer Risk in Families with Mutations in PALB2
10.1056/nejmoa1400382 · ExternalCitation · doi-reference
Incidental Germline Variants in 1000 Advanced Cancers on a Prospective Somatic Genomic Profiling Protocol
10.1093/annonc/mdw018 · ExternalCitation · doi-reference
Feasibility and Utility of a Panel Testing for 114 Cancer-Associated Genes in a Clinical Setting: A Hospital-Based Study
10.1111/cas.13969 · ExternalCitation · doi-reference
Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality
10.1158/1078-0432.ccr-24-2058 · ExternalCitation · doi-reference
CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls
10.1200/jco.2007.12.5922 · ExternalCitation · doi-reference
Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants
10.1200/jco.21.02112 · ExternalCitation · doi-reference
